Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

Samankaltaisia teoksia

• Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model
  Tekijä: MacGowan, Alasdair P., et al.
  Julkaistu: (2003)
• Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic Model
  Tekijä: MacGowan, Alasdair P., et al.
  Julkaistu: (2003)
• Activity of Moxifloxacin, Administered Once a Day, against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model of Infection
  Tekijä: MacGowan, Alasdair P., et al.
  Julkaistu: (1999)
• Pharmacodynamics of Moxifloxacin against Anaerobes Studied in an In Vitro Pharmacokinetic Model
  Tekijä: Noel, Alan R., et al.
  Julkaistu: (2005)
• Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model
  Tekijä: Bowker, Karen E., et al.
  Julkaistu: (2008)